ConductScience.org, home

Company · exactech-0846a969

Exactech

4 sourcescompanies-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. Exactech. Companies, record exactech-0846a969. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/exactech-0846a969

On this page

Company

The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.

Name
Exactech
Trials
18
As lead sponsor
17
As collaborator
1
Recruiting
8
Active, recruiting or not
10
Completed
1
Stopped early, withdrawn or suspended
7
Posted results
0
Trials by phase
Phase 4 1
Drugs its trials test
0
Comparisons calculated in its trials
0
First trial registered
2005-11-17
Last update
2026-09-17

Source ClinicalTrials.gov

Pipeline0

The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.

None in this release.

Trials18

The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.

TrialTitleRolePhaseStatusTypeParticipantsStartResults first postedDrugsIn TrialsSource
NCT07107581Exactech Knee Systems Post Market Clinical Follow-upLead sponsorEnrolling by invitationObservational1,8792023-12-01https://conductscience.org/library/trials/NCT07107581ClinicalTrials.gov
NCT06678750A Prospective Clinical Study Evaluating the Newton™ TKA ProtocolCollaboratorNot applicableWithdrawnInterventional02024-12https://conductscience.org/library/trials/NCT06678750ClinicalTrials.gov
NCT05849961Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)Lead sponsorRecruitingObservational2,9462023-10-13https://conductscience.org/library/trials/NCT05849961ClinicalTrials.gov
NCT05788757Optetrak Knee System Post Market Clinical Follow-UpLead sponsorActive, not recruitingObservational4,5882011-06-01https://conductscience.org/library/trials/NCT05788757ClinicalTrials.gov
NCT05703958Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-upLead sponsorRecruitingObservational1512023-04-19https://conductscience.org/library/trials/NCT05703958ClinicalTrials.gov
NCT05691868Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)Lead sponsorRecruitingObservational4002019-04-08https://conductscience.org/library/trials/NCT05691868ClinicalTrials.gov
NCT05653102A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee SystemLead sponsorRecruitingObservational1,0002019-01-23https://conductscience.org/library/trials/NCT05653102ClinicalTrials.gov
NCT05619588Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US OnlyLead sponsorRecruitingObservational3702017-04-04https://conductscience.org/library/trials/NCT05619588ClinicalTrials.gov
NCT05615259Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder ArthroplastyLead sponsorRecruitingObservational2602020-09-23https://conductscience.org/library/trials/NCT05615259ClinicalTrials.gov
NCT05615246Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)Lead sponsorTerminatedObservational42018-09-05https://conductscience.org/library/trials/NCT05615246ClinicalTrials.gov

1 to 10 of 18

See all 18 trials

Conditions31

The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.

ConditionTrials
Knee Arthroplasty, Total4
Osteoarthritis3
Rheumatoid Arthritis3
Arthritis of Ankle2
Failure, Prosthesis2
Ankle Rheumatoid Arthritis1
Ankylosing Spondylitis1
Arthritis and/or Post-traumatic Degenerative Problems1
Arthropathy of Knee1
Comparison1

Partners1

The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.

OrganizationClassTrials sharedIn Companies
Newton-Wellesley HospitalOther1

Data dates

The date of each source this release read.

Sponsors and results posted
2026-11-14
ClinicalTrials.gov
Trials' registrations
2026-11-12
ClinicalTrials.gov
Drug links and targets
2026-09-18
Open Targets
Comparisons
2026-03-23
Trial comparisons

Sources 4

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL
  • ClinicalTrials.govNo license stated
  • Open TargetsCC0 1.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this company from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/companies/v1/exactech-0846a969

GET https://conductscience.org/api/companies/v1/exactech-0846a969/conditions?page=2